Connection

Gunnar Gislason to Recurrence

Back to Details
This is a "connection" page, showing publications Gunnar Gislason has written about Recurrence.
Gunnar Gislason
Connection Strength
0.151
Recurrence
  1. Safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism: a nationwide study. Eur Heart J Cardiovasc Pharmacother. 2018 10 01; 4(4):220-227.
    View in: PubMed
    Score: 0.023
  2. Comparative thromboembolic risk in atrial fibrillation patients with and without a concurrent infection. Am Heart J. 2018 10; 204:43-51.
    View in: PubMed
    Score: 0.022
  3. Association of Timing of Aortic Valve Replacement Surgery After Stroke With Risk of Recurrent Stroke and Mortality. JAMA Cardiol. 2018 06 01; 3(6):506-513.
    View in: PubMed
    Score: 0.022
  4. Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study. Eur Heart J. 2018 05 14; 39(19):1698-1705a.
    View in: PubMed
    Score: 0.022
  5. Temporal trends in atrial fibrillation recurrence rates after ablation between 2005 and 2014: a nationwide Danish cohort study. Eur Heart J. 2018 02 07; 39(6):442-449.
    View in: PubMed
    Score: 0.022
  6. Risk of Infective Endocarditis in Patients with End Stage Renal Disease. Clin J Am Soc Nephrol. 2017 Nov 07; 12(11):1814-1822.
    View in: PubMed
    Score: 0.021
  7. Comparative safety and effectiveness of rivaroxaban versus VKAs in patients with venous thromboembolism. A Danish nationwide registry-based study. Thromb Haemost. 2017 06 02; 117(6):1182-1191.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.